Neurontin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postherpetic neuralgia and some types of seizures. In people with myeloma, neurontin is sometimes prescribed to treat neuropathic (nerve) pain, a common side effect of myeloma treatment. Neurontin is also referred to by its drug name, Gabapentin.
Neurontin is an anticonvulsant, or drug that controls seizures. Neurontin is believed to work on certain types of pain by reducing pain signals sent by damaged nerves.
How do I take it?
Prescribing information states that Neurontin should be taken three times a day.
Neurontin comes in tablet, capsule, and liquid solution forms.
The FDA-approved label for Neurontin lists common side effects including sleepiness, dizziness, and peripheral edema (swelling in the hands and feet).
Rare but serious side effects listed for Neurontin include worsening depression, suicidal thoughts, and severe hypersensitivity reactions.
For more details about this treatment, visit:
Neurontin highlights of prescribing information – Pfizer
Peripheral neuropathy – Myeloma UK
Managing Treatment-related Peripheral Neuropathy in Patients with Multiple Myeloma – OncologyNurseAdvisor